BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22113109)

  • 1. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo.
    Zhou H; Fei W; Bai Y; Zhu S; Luo E; Chen K; Hu J
    Eur J Cancer Prev; 2012 May; 21(3):289-99. PubMed ID: 22113109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
    Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
    Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypoxia inducible factor-1alpha (HIF-1alpha) on the growth & adhesion in tongue squamous cell carcinoma cells.
    Song Y; Wang W; Qu X; Sun S
    Indian J Med Res; 2009 Feb; 129(2):154-63. PubMed ID: 19293442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.
    Ishikawa T; Nakashiro K; Klosek SK; Goda H; Hara S; Uchida D; Hamakawa H
    Oncol Rep; 2009 Mar; 21(3):707-12. PubMed ID: 19212630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
    Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
    Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.
    Jeong JH; Jeong YJ; Cho HJ; Shin JM; Kang JH; Park KK; Park YY; Chung IK; Chang HW; Magae J
    J Cell Biochem; 2012 Apr; 113(4):1302-13. PubMed ID: 22109717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells.
    Sasabe E; Tatemoto Y; Li D; Yamamoto T; Osaki T
    Cancer Sci; 2005 Jul; 96(7):394-402. PubMed ID: 16053510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The inhibition of VEGF expression induced by HIF-1alpha RNA interference].
    Pan K; Luo F; Liu X; Wang Y; Li Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1133-6, 1166. PubMed ID: 18027712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer.
    Kishimoto K; Yoshida S; Ibaragi S; Yoshioka N; Okui T; Hu GF; Sasaki A
    Oral Oncol; 2012 Nov; 48(11):1120-7. PubMed ID: 22694909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of HIF-1alpha suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis.
    Xu K; Ding Q; Fang Z; Zheng J; Gao P; Lu Y; Zhang Y
    Cancer Gene Ther; 2010 Mar; 17(3):212-22. PubMed ID: 19816521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of silencing hypoxia-inducible factor-1 alpha by RNA interference on human breast carcinoma cell line].
    Wang H; Liu YJ; Han ZB; Liang LH; Lv LL; Han ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):670-4. PubMed ID: 17121229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor cell growth in the liver by RNA interference-mediated suppression of HIF-1alpha expression in tumor cells and hepatocytes.
    Takahashi Y; Nishikawa M; Takakura Y
    Gene Ther; 2008 Apr; 15(8):572-82. PubMed ID: 18273056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma.
    Kimura S; Kitadai Y; Tanaka S; Kuwai T; Hihara J; Yoshida K; Toge T; Chayama K
    Eur J Cancer; 2004 Aug; 40(12):1904-12. PubMed ID: 15288294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
    Gillespie DL; Whang K; Ragel BT; Flynn JR; Kelly DA; Jensen RL
    Clin Cancer Res; 2007 Apr; 13(8):2441-8. PubMed ID: 17438103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.